Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19

Bibliographic Details
Title: Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19
Authors: Tanja M. Müller, Emily Becker, Maximilian Wiendl, Lisa Lou Schulze, Caroline Voskens, Simon Völkl, Andreas E. Kremer, Markus F. Neurath, Sebastian Zundler
Source: Frontiers in Immunology, Vol 12 (2021)
Publisher Information: Frontiers Media S.A., 2021.
Publication Year: 2021
Collection: LCC:Immunologic diseases. Allergy
Subject Terms: COVID-19, SARS-CoV-2 infection, T cell trafficking, integrins, gut homing, Immunologic diseases. Allergy, RC581-607
More Details: BackgroundInfection with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a wide range of symptoms including gastrointestinal manifestations, and intestinal epithelial cells are a target of the virus. However, it is unknown how the intestinal immune system contributes to systemic immune responses in coronavirus disease 2019 (COVID-19).MethodsWe characterized peripheral blood lymphocytes from patients with active COVID-19 and convalescent patients as well as healthy controls by flow cytometry.ResultsThe frequency and absolute number of circulating memory T and B cells expressing the gut homing integrin α4β7 integrin was reduced during COVID-19, whether gastrointestinal symptoms were present or not. While total IgA-expressing B cells were increased, gut-imprinted B cells with IgA expression were stable.ConclusionCOVID-19 is associated with a decrease in circulating adaptive immune cells expressing the key gut homing marker α4β7 suggesting that these cells are preferentially recruited to extra-intestinal tissues independently of α4β7 or that the systemic immune response against SARS-CoV-2 is at least numerically dominated by extraintestinal, particularly pulmonary, immune cell priming.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1664-3224
Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2021.639329/full; https://doaj.org/toc/1664-3224
DOI: 10.3389/fimmu.2021.639329
Access URL: https://doaj.org/article/aa7dc904cbf64fedb1240afb7bb42d87
Accession Number: edsdoj.7dc904cbf64fedb1240afb7bb42d87
Database: Directory of Open Access Journals
More Details
ISSN:16643224
DOI:10.3389/fimmu.2021.639329
Published in:Frontiers in Immunology
Language:English